New urgency to update CDRH (Center for Devices and Radiological Health) guidance, FDA tells AdvaMed
This article was originally published in Clinica
The FDA's Center for Devices and Radiological Health is experimenting with ways to put more resources into the badly needed task of updating guidance documents, agency officials said at AdvaMed's 15th annual device submissions workshop.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.